HotSheets 2007  

January - March | April - June | July - September | October - Decembar

2007 Us TOO HotSheet Article Index


January | View Newsletter

February | View Newsletter

March | View Newsletter


  • President’s Message: Taking Action in 2007

  • Feb Conf Call: "Intimacy & Prostate Cancer"

  • Companies, Chapters Signing Up for Sneakers@Work Day

  • New Tests of Dendreon’s Prostate Cancer

  • Doc Moyad’s What Works and What is Worthless Column: Vitamin D—Part II

  • Read more..


  • President’s Message: “What Is Awareness?

  • Special Thanks to Joe Piper

  • The Year in Prostate Cancer: Part I of II

  • Doc Moyad’s What Works and What is Worthless Column: Vitamin D—Part III

  • Feb. 13th Conference Call:
    Intimacy & Prostate Cancer

  • 2nd Annual Us TOO Online Auction
    Announced, Seeking Donated Items for Bid

  • Read more..


  • Survivor Rate Highest with Prostatectomy for Localized Prostate Cancer

  • New Members for Us TOO Board of Directors

  • The Year in Prostate Cancer, Part II

  • Medicare Part D and Erectile Dysfunction

  • Leading by Example

  • PROVENGE® Granted FDA Priority Review

  • Read more..


April | View Newsletter

MAY | View Newsletter

June | View Newsletter


  • Special Burning Issues Supplement: Highlights from the 2007 Multidisciplinary Prostate Cancer Symposium - February 21-24, 2007, Orlando, FL

  • GPC Biotech Provides Satraplatin for Free

  • Calcitriol with Docetaxel Boosts Survival

  • The Year in Prostate Cancer - Part 3

  • Estrogen Therapy: DES (Diethylstilbestrol)

  • Doc Moyad’s What Works and What is Worthless Column: Zinc supplementation?

  • Read more..


  • Special Burning Issues Supplement: Prostate cancer and incontinence: coping strategies and treatment options

  • MRI in Managing Prostate Cancer

  • FDA Panel Backs New Prostate Vaccine

  • Adjuvant ADT Can “Cure” Nonmetastasized Prostate Cancer

  • Alendronate Increases BMD in Prostate Cancer Patients Receiving ADT

  • Doc Moyad’s What Works and What is Worthless Column—Lycopene

  • Read more..


  • Doc Moyad’s What Works and What is Worthless Column—Provenge®

  • Cell Genesis Reports Phase II Results with GVAX Immunotherapy

  • A Survivor Reviews the 2007 ASCO Prostate Cancer Symposium

  • UCSD Researchers Report Ability to Detect Cancer at Earliest, Curable Stage

  • New Blood Test for Prostate Cancer—Can EPCA-2 be on the Horizon?

  • Possible New Cancer Treatment? Antifungal Drug Stops Blood Vessel Growth

  • Read more..


July | View Newsletter

August | View Newsletter September | View Newsletter


  • New AUA Prostate Cancer Guidelines

  • FDA Requirements for Provenge® Licensure

  • Consider Source of Localized Prostate Cancer Recommendations

  • Dendreon Sued after Provenge’s Ok Put Off

  • 223Radium in Hormone-Refractory Cancer

  • Update:Outcomes with Primary Therapy for Intermediate Risk Prostate Cancer

  • Read more..

  • New Data from ASCO on SPARC Trial

  • Us TOO University in Austin, Texas “A Marvelous Evening”

  • Survivorship Care Plan Is an Important Part of Cancer Care

  • Sneakers@ Work Day, Great Fun, Great Success

  • F-18 Fluor Choline PET/CT Assesses Bone Metastases in Prostate Cancer

  • New Procedure Minimizes Post-Prostatectomy Incontinence

  • Read more..

  • Court Sees No Right to Unapproved Drugs

  • FDA Requests More Data on Satraplatin

  • Hormone Inhibitor Promising For Hard-to-Treat Prostate Cancer

  • FDA Sued Over Provenge Delay

  • Botox for Treating Prostate Problems

  • Doc Moyad’s “No Bogus Science” Column

  • Friday the 13th Lucky for Prostate Pointers

  • Read more..


October | View Newsletter

November | View Newsletter

December | View Newsletter


  • CMS Proposal Would Virtually Eliminate Medicare Clinical Trials Coverage

  • Statins Fail to Cut the Androgens that Fuel Prostate Cancer

  • Stress Management before Prostatectomy

  • First Biomarker Discovered that Predicts Prostate Cancer Outcome

  • Prostate Px® Test Results Published

  • Doc Moyad’s What Works and What is Worthless Column

  • Read more..


  • Charity Navigator Gives Us TOO 4-Star Rating

  • Gleason Score and Prostate Cancer Prognosis

  • New Study Refutes Belief that Black Men Have More Aggressive Prostate Cancer

  • Us TOO Reaches Out to Federal Employees and Military

  • Nomogram Can Predict Life Expectancy

  • oc Moyad’s What Works and What is Worthless Column—Ginseng

  • Read more..


  • Us TOO’s 2006 Annual Report Now Available

  • New Free Kits for Newly-Diagnosed Men

  • Survival Analysis from the SPARC Trial

  • Us TOO University Chicago Program a Success

  • October 30th Intimacy Teleconference a Success

  • Biopsy Site Affects Prostate Cancer Detection

  • Read more..


Facebook -  Twitter -  LinkedIn - Inspire prostate cancer discussions – 

Contact Us | Privacy Policy | Terms & Conditions | Disclaimer   

Copyright © 2005-2017 Us TOO International, Inc.
Designed and hosted by ACCESS Medical Group, Ltd.